| Similar Articles |
|---|
 |
Chemistry World
August 5, 2014
Dinsa Sachan |
Price caps provoke lawsuits from Indian pharma industry The Indian pharma industry is engaged in a pitched battle with the drug price regulator that recently brought certain drugs under price control.   |
The Motley Fool
September 9, 2004
Charly Travers |
The Case for Drug Stocks The reports of the drug industry's death are greatly exaggerated. |
The Motley Fool
March 15, 2004
W.D. Crotty |
60 Minutes on Drugs Will the weekly news magazine's prime-time slam rattle the drug stocks? |
The Motley Fool
March 18, 2004
Brian Gorman |
The Drug Cost Conundrum While drug prices continue to climb, the public and its representatives in government are demanding cheaper pharmaceuticals. The industry is not likely to find cover in Medicare biotechnology. Instead, investors should look for drug makers that are finding ways to operate leaner and meaner. |
BusinessWeek
April 18, 2005
Manjeet Kripalani |
India: Bigger Pharma Tougher patent protection laws are spurring rapid growth in new drug research across India. |
The Motley Fool
April 22, 2009 |
3 Stocks Hitting Low Notes This pharma stock has hit bottom. Is it ready to bounce? Take a look at: Pharmaceutical Product Development... |
Pharmaceutical Executive
April 1, 2014
Subramanian et al. |
"Market-Based" Price Controls In India? Three strategic implications for pharma pricing strategies in India. |
The Motley Fool
November 30, 2010
Brian Orelli |
A Witty Response to Pharma's R&D Dilemma According to GlaxoSmithKline CEO Andrew Witty, the pharmaceutical industry is a mess. That's the basic gist of his opinion piece in The Economist. |
The Motley Fool
June 8, 2006
Tim Hanson |
Should You Short Small Caps? After years of reward, so-called contrarians are now turning up their noses at the small-cap fad. |
Pharmaceutical Executive
May 1, 2007 |
Thoughtleader: Thomas Nagle, Strategic Pricing Group This industry consultant believes the U.S. government will soon follow Europe's lead in taking a greater hand in price negotiations, and pharma will need to be able to communicate the value that products offer. Here he discusses how pharma can meet that challenge. |
The Motley Fool
December 22, 2005
Bill Barker |
50 Years of Market Whomping Time-tested strategies are good all the time. Small caps had a better year than large caps -- again. And value stocks outperformed growth stocks -- again. |
IndustryWeek
August 18, 2010
Wilbur Reid |
Consider This -- Why Companies Need a Chief Pricing Officer In the new order, the rise of strategic pricing roles such as a chief pricing officer and supporting pricing team will help companies achieve strong financial performance. |
Investment Advisor
October 2005
Ben Warwick |
The Puzzler: Large Cap or Small? We all know that when it comes to stocks, size matters. But bigger isn't always better, especially when the subject under discussion is the equity market. |
The Motley Fool
August 12, 2004
Tom Gardner |
3 Tools for Small-Cap Success Here are tips to track long-range trends. |
The Motley Fool
May 18, 2011
Matt Koppenheffer |
Can You Really Make Money in Blue Chips? There are good opportunities among the large caps, but you have to be choosy. |
BusinessWeek
March 13, 2006
Aaron Pressman |
A Small-Cap World After All Are large-cap returns really due to pull ahead? Don't bet on it |
Reason
April 2001
Ronald Bailey |
Goddamn the Pusher Man Why does everybody seem to hate the pharmaceutical industry? |
The Motley Fool
October 19, 2007
Tim Beyers |
Hot Stocks You're Buying Now The top three performing industries in the past 30 days have been dry-bulk shipping, Chinese Industries, and Greek companies. Here are some of the hottest stocks in those segment: Omega Navigation Enterprises... China Fire & Security...Navios Maritime... |
Financial Advisor
October 2005
Raymond Fazzi |
Small Caps Look To Extend Streak Performing like Wall Street's version of The Little Engine That Could, small-cap equities are in a neck-and-neck race to outperform the large-cap sector for the sixth straight year. |
Financial Advisor
September 2009
Raymond Fazzi |
A Small Risk Conventional wisdom says small caps are riskier than their large-cap counterparts, but they remain a basic building block in retirement portfolios. |
The Motley Fool
June 14, 2011
Adam J. Wiederman |
Prevent Large Caps from Killing Your Returns Investors can easily gain some additional income from large caps by trading options. |
The Motley Fool
May 27, 2005
Bill Barker |
$40 Billion Small Caps How your "small-cap" fund might own some of the biggest companies in the market. |
IndustryWeek
April 1, 2008
Nick Zubko |
Price Check on Manufacturing A benchmarking survey polled more than 500 pricing professionals in manufacturing, distribution and industrial services to shed light on their methods, perceptions and trends in pricing practices and capabilities. |
The Motley Fool
February 6, 2006
Tim Hanson |
325 Incredible Returns Small caps are one area of the market where the individual investor has the opportunity to earn phenomenal returns, but there are also pitfalls. Investors must consider their investments very carefully. |
